Population pharmacokinetics of ritonavir-boosted atazanavir in subsequent-line treatment in African children with HIV.
Saved in:
| Title: | Population pharmacokinetics of ritonavir-boosted atazanavir in subsequent-line treatment in African children with HIV. |
|---|---|
| Authors: | van Dyk J; Division of Clinical Pharmacology, Department of Medicine, University of Cape Town, Cape Town, South Africa., Waitt C; Infectious Diseases Institute, Makerere University College of Health Sciences, Kampala, Uganda.; Department of Women's and Children's Health, University of Liverpool, Liverpool, United Kingdom., Mugerwa H; Joint Clinical Research Centre, Lubowa, Uganda., Wiesner L; Division of Clinical Pharmacology, Department of Medicine, University of Cape Town, Cape Town, South Africa., Orrell C; Desmond Tutu HIV Centre, University of Cape Town, Cape Town, South Africa.; HIV and Infectious Diseases Unit, South African Medical Research Council, Cape Town, South Africa., Bamford A; Medical Research Council Clinical Trials Unit at University College London, London, England, United Kingdom.; Infection, Immunity & Inflammation Department, UCL Great Ormond Street Hospital Institute of Child Health, London, United Kingdom., Gibb DM; Medical Research Council Clinical Trials Unit at University College London, London, England, United Kingdom., McIlleron HM; Division of Clinical Pharmacology, Department of Medicine, University of Cape Town, Cape Town, South Africa.; Wellcome Centre for Infectious Diseases Research in Africa, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa., Colbers A; Department of Pharmacy, Pharmacology & Toxicology, Radboud University Medical Center, Nijmegen, the Netherlands., Burger DM; Department of Pharmacy, Pharmacology & Toxicology, Radboud University Medical Center, Nijmegen, the Netherlands., Denti P; Division of Clinical Pharmacology, Department of Medicine, University of Cape Town, Cape Town, South Africa., Wasmann RE; Division of Clinical Pharmacology, Department of Medicine, University of Cape Town, Cape Town, South Africa. |
| Source: | Antimicrobial agents and chemotherapy [Antimicrob Agents Chemother] 2026 Jul 17, pp. e0059226. Date of Electronic Publication: 2026 Jul 17. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: American Society for Microbiology Country of Publication: United States NLM ID: 0315061 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1098-6596 (Electronic) Linking ISSN: 00664804 NLM ISO Abbreviation: Antimicrob Agents Chemother Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 42467063 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Population pharmacokinetics of ritonavir-boosted atazanavir in subsequent-line treatment in African children with HIV. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22van+Dyk+J%22">van Dyk J</searchLink>; Division of Clinical Pharmacology, Department of Medicine, University of Cape Town, Cape Town, South Africa.<br /><searchLink fieldCode="AU" term="%22Waitt+C%22">Waitt C</searchLink>; Infectious Diseases Institute, Makerere University College of Health Sciences, Kampala, Uganda.; Department of Women's and Children's Health, University of Liverpool, Liverpool, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Mugerwa+H%22">Mugerwa H</searchLink>; Joint Clinical Research Centre, Lubowa, Uganda.<br /><searchLink fieldCode="AU" term="%22Wiesner+L%22">Wiesner L</searchLink>; Division of Clinical Pharmacology, Department of Medicine, University of Cape Town, Cape Town, South Africa.<br /><searchLink fieldCode="AU" term="%22Orrell+C%22">Orrell C</searchLink>; Desmond Tutu HIV Centre, University of Cape Town, Cape Town, South Africa.; HIV and Infectious Diseases Unit, South African Medical Research Council, Cape Town, South Africa.<br /><searchLink fieldCode="AU" term="%22Bamford+A%22">Bamford A</searchLink>; Medical Research Council Clinical Trials Unit at University College London, London, England, United Kingdom.; Infection, Immunity & Inflammation Department, UCL Great Ormond Street Hospital Institute of Child Health, London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Gibb+DM%22">Gibb DM</searchLink>; Medical Research Council Clinical Trials Unit at University College London, London, England, United Kingdom.<br /><searchLink fieldCode="AU" term="%22McIlleron+HM%22">McIlleron HM</searchLink>; Division of Clinical Pharmacology, Department of Medicine, University of Cape Town, Cape Town, South Africa.; Wellcome Centre for Infectious Diseases Research in Africa, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa.<br /><searchLink fieldCode="AU" term="%22Colbers+A%22">Colbers A</searchLink>; Department of Pharmacy, Pharmacology & Toxicology, Radboud University Medical Center, Nijmegen, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Burger+DM%22">Burger DM</searchLink>; Department of Pharmacy, Pharmacology & Toxicology, Radboud University Medical Center, Nijmegen, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Denti+P%22">Denti P</searchLink>; Division of Clinical Pharmacology, Department of Medicine, University of Cape Town, Cape Town, South Africa.<br /><searchLink fieldCode="AU" term="%22Wasmann+RE%22">Wasmann RE</searchLink>; Division of Clinical Pharmacology, Department of Medicine, University of Cape Town, Cape Town, South Africa. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%220315061%22">Antimicrobial agents and chemotherapy</searchLink> [Antimicrob Agents Chemother] 2026 Jul 17, pp. e0059226. <i>Date of Electronic Publication: </i>2026 Jul 17. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Society+for+Microbiology%22">American Society for Microbiology </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>0315061 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1098-6596 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200664804%22">00664804 </searchLink><i>NLM ISO Abbreviation: </i>Antimicrob Agents Chemother <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42467063 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1128/aac.00592-26 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: e0059226 Titles: – TitleFull: Population pharmacokinetics of ritonavir-boosted atazanavir in subsequent-line treatment in African children with HIV. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: van Dyk J – PersonEntity: Name: NameFull: Waitt C – PersonEntity: Name: NameFull: Mugerwa H – PersonEntity: Name: NameFull: Wiesner L – PersonEntity: Name: NameFull: Orrell C – PersonEntity: Name: NameFull: Bamford A – PersonEntity: Name: NameFull: Gibb DM – PersonEntity: Name: NameFull: McIlleron HM – PersonEntity: Name: NameFull: Colbers A – PersonEntity: Name: NameFull: Burger DM – PersonEntity: Name: NameFull: Denti P – PersonEntity: Name: NameFull: Wasmann RE IsPartOfRelationships: – BibEntity: Dates: – D: 17 M: 07 Text: 2026 Jul 17 Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1098-6596 Titles: – TitleFull: Antimicrobial agents and chemotherapy Type: main |
| ResultId | 1 |